Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537751) titled 'Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis' on April 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Noura Abdelmoneim Mohammed Elseessy

Condition: Atopic Dermatitis Eczema

Intervention: Drug: Crisaborole 2% topical ointment

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 1, 2024

Target Sample Size: 40

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/...